Murat Ugur, MD, Rakesh M. Suri, MD, DPhil, Richard C

Slides:

Advertisements

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Of mice and men and surgical transcatheter aortic valve insertion

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

A 20-year experience with isolated pericardiectomy: Analysis of indications and outcomes Erin A. Gillaspie, MD, John M. Stulak, MD, Richard C. Daly,

Early structural valve deterioration of the Trifecta aortic valve biological prosthesis: A word of caution Pankaj Saxena, FRACS, PhD, Kevin L. Greason,

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Scott Goldman, MD, Anson Cheung, MD, Joseph E. Bavaria, MD, Michael R

Left ventricular dysfunction after mitral valve repair—the fallacy of “normal” preoperative myocardial function Eduard Quintana, MD, Rakesh M. Suri,

Juan C. Araque, MD, Kevin L. Greason, MD, Zhuo Li, MS, Courtney N

Mitral valve-in-valve hemodynamic performance: An in vitro study

The new St Jude Trifecta versus Carpentier-Edwards Perimount Magna and Magna Ease aortic bioprosthesis: Is there a hemodynamic superiority? Daniel Wendt,

Bigger valve size is not always better

Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years Jian Ye, MD, FRCSC, John G. Webb, MD,

Association between indices of prosthesis internal orifice size and operative mortality after isolated aortic valve replacement Charles R. Bridges, MD,

Harold M. Burkhart, MD, Jeffrey B. Riley, CCP, Sarah E

Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing Jess L. Thompson, MD, Harold M. Burkhart, MD,

Hirokazu Fujimoto, MD, PhD, Meghana R. K

Impact of Left Ventricular Systolic Function on Outcome of Correction of Chronic Severe Aortic Valve Regurgitation: Implications for Timing of Surgical.

Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: A problem of the leaflets or of the stent? Giuseppe Santarpino, MD, Steffen.

Where is the common sense in aortic valve replacement

Bicuspid aortic valve aortopathy: One size fits all?

The St Jude Medical Trifecta aortic pericardial valve: Results from a global, multicenter, prospective clinical study Joseph E. Bavaria, MD, Nimesh D.

Early hemodynamic performance of the third generation St Jude Trifecta aortic prosthesis: A systematic review and meta-analysis Kevin Phan, BS, Hakeem.

Starr–Edwards aortic valve: Forty-four years old and still working!

Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: When is preoperative coronary angiography necessary? Nassir M.

Management of Mild Aortic Stenosis at the Time of Coronary Artery Bypass Surgery: Should the Valve Be Replaced? Basar Sareyyupoglu, MD, Thoralf M. Sundt,

Outcomes after mechanical aortic valve replacement in children and young adults with congenital heart disease Patrick O. Myers, MD, Suyog A. Mokashi,

Vikas Sharma, MBBS, Rakesh M. Suri, MD, DPhil, Joseph A

Surgical ablation for atrial fibrillation for two decades: Are the results of new techniques equivalent to the Cox maze III procedure? John M. Stulak,

Open aortic arch reconstruction after previous cardiac surgery: Outcomes of 168 consecutive operations Eduard Quintana, MD, FETCS, Pietro Bajona, MD,

John R. Spratt, MD, MA, Sara J. Shumway, MD

The role of cognitive dissonance in the management of functional tricuspid regurgitation at the time of degenerative mitral valve repair Rakesh M. Suri,

Sometimes an ounce of extracorporeal membrane oxygenation prevention is worth a pound of extracorporeal membrane oxygenation cure Pankaj Saxena, FRACS,

It's not “just a shunt” but sometimes it should be…

Simple interrupted suturing increases valve performance after aortic valve replacement with a small supra-annular bioprosthesis Minoru Tabata, MD, MPH,

A simple modification to lower incidence of heart block with sutureless valve implantation Bobby Yanagawa, MD, PhD, Jorge Cruz, MD, Lyna Boisvert, RN,

Do differences in early hemodynamic performance of current generation biologic aortic valves predict outcomes 1 year following surgery? Nassir M. Thalji,

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Stent and leaflet stresses in a 26-mm first-generation balloon-expandable transcatheter aortic valve Yue Xuan, PhD, Kapil Krishnan, PhD, Jian Ye, MD,

The Journal of Thoracic and Cardiovascular Surgery

Conventional redo biological valve replacement over 20 years: Surgical benchmarks should guide patient selection for transcatheter valve-in-valve therapy

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Replicating the success of mitral valve repair in the aortic valve

Juan G. Penaranda, MD, Kevin L. Greason, MD, Sorin V

St Jude Medical Regent valve

Mycobacterium chimaera: The ethical duty to disclose the minimal risk of infection to exposed patients Anita Nguyen, MBBS, C. Christopher Hook, MD, Joseph.

Morgan L. Brown, MD, Hartzell V. Schaff, MD, Zhuo Li, MS, Rakesh M

Vikas Sharma, MBBS, Harold M. Burkhart, MD, Joseph A

Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: Establishing the benchmark against which percutaneous.

Rakesh M. Suri, MD, DPhil, Joseph A

The Mitroflow aortic valve: A past, present, and future illuminated

Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: Factors that influence survival Simon Maltais,

Suture technique does not affect hemodynamic performance of the small supra-annular Trifecta bioprosthesis Murat Ugur, MD, John G. Byrne, MD, MBA, FACC,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Basar Sareyyupoglu, MD, Hartzell V. Schaff, MD, Rakesh M

Cardiac Myxomas: A 50-Year Experience With Resection and Analysis of Risk Factors for Recurrence Ishan K. Shah, MD, Joseph A. Dearani, MD, Richard C.

Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome Jess L. Thompson, MD, Hartzell V. Schaff,

Bicuspid aortopathy: Seeing the forest for the trees

Pasquale Totaro, MD, Vincenzo Argano, MD

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse Rakesh M. Suri, MD, DPhil, Hartzell.

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: Should hemodynamic performance influence device selection? Rakesh.

The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: Implications for revascularization in the transcatheter.

Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Presentation transcript:

Comparison of early hemodynamic performance of 3 aortic valve bioprostheses Murat Ugur, MD, Rakesh M. Suri, MD, DPhil, Richard C. Daly, MD, Joseph A. Dearani, MD, Soon J. Park, MD, Lyle D. Joyce, MD, PhD, Harold M. Burkhart, MD, Kevin L. Greason, MD, Hartzell V. Schaff, MD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 5, Pages 1940-1946 (November 2014) DOI: 10.1016/j.jtcvs.2013.12.051 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Discharge echocardiographic findings for 1436 patients stratified by valve size for the Trifecta (St Jude Medical, St Paul, Minn), Mitroflow (Sorin Group, Milan, Italy), and Perimount Magna (Edwards Lifesciences Corp, Irvine, Calif) bovine aortic valve bioprostheses. Top of box-and-whiskers plots shows that the average mean gradient was significantly lower across valve sizes (19 mm, 21 mm, 23 mm, 25 mm, and ≥27 mm) for the Trifecta valve. Middle shows that the mean EOA was significantly greater across valve sizes for the Trifecta valve. Bottom shows that the mean EOAI was significantly higher across valve sizes for the Trifecta valve. Mean and median are represented by the diamond and horizontal line, respectively, inside each colored box. Area between the top and bottom borders (ie, whiskers) represents the middle 50% of the data. EOA, Effective orifice area; EOAI, effective orifice area index; MG, mean gradient. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 1940-1946DOI: (10.1016/j.jtcvs.2013.12.051) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions